Tagrix 80 mg, with the active ingredient Osimertinib, is a targeted therapy used primarily for the treatment of non-small cell lung cancer (NSCLC). This medication is specifically designed for patients whose cancer has certain types of abnormal epidermal growth factor receptor (EGFR) genes, which can be identified through genetic testing. Mechanism of ActionTagrix 80 Mg (Osimertinib) belongs to...